Specifically, in the SBECD + OTX + CHR treatment group, TIMP-1, MMP-2, MMP-3, and MMP-9 expressions dropped approximately by about 29.04, 15.12, 58.77, and 19.41 times, respectively, compared to the diabetes group. This evidence concerns the gene MMP9 and diabetes mellitus.